Transcript Slide Presentation - Powerpoint

BLOODBORNE PATHOGENS
Purpose
• Reduce / eliminate exposure potential
• Comply with Ohio’s Public Employment
Risk Reduction Act (reference OSHA)
2
Exposure Determination
•Employees in the following job classifications have
reasonably anticipated occupational exposure:
–Physicians, nurses, and lab technicians at SHC; Nursing Faculty
–Trainers in Intercollegiate Athletics
–Employees with first aid responsibilities at the Ice Arena
–RSC: Lifeguards, Facility Managers, Outdoor Pursuit Center
–First aiders in Child Studies
–University Police Officers
–BSW / BRW who may clean-up blood/body fluid in a work area
–Chemistry/Biochemistry, Kinesiology who work with blood products
3
Topics
Bloodborne diseases and their transmission
Reducing exposure potential
Exposure incidents
Hepatitis B vaccine
Spill cleanup
4
Bloodborne diseases and
their transmission
•Percutaneous, parenteral (i.e., through the skin layer)
•Contact with mucous membranes of eyes, nose, mouth
(via splash, direct contact)
•Sex with infected partner
•Maternal-Neonatal (i.e., mother to unborn child/infant)
Significant risk variables:
volume, concentration, mode of transmission, immune status
5
Bloodborne diseases and their transmission
Universal Precautions
A simple approach to infection control.
A concept that assumes that all human
blood and certain human body fluids are
treated as if known to be infected by
bloodborne pathogens.
Always Presume Contamination
6
Bloodborne diseases and their transmission
Terms
•BBP (bloodborne pathogens)
•HIV (human immunodeficiency virus)
•AIDS (acquired immunodeficiency syndrome)
•HBV (hepatitis B virus)*
•OPIM (other potentially infectious materials)
*or one of the other hepatitis viruses
(e.g., HCV)
7
Bloodborne diseases and their transmission
Other Potentially Infectious Materials
OPIM
•Semen and vaginal secretions
•Saliva (in dental procedures)
•ANY body fluid visibly contaminated with blood
•ALL body fluids in situations where it is difficult or
impossible to differentiate between body fluids
•Other internal fluids from the brain or spine, joints,
lungs, around the heart or abdomen, or in the womb
•Any unfixed (not preserved) human tissue or organ
8
Bloodborne diseases and their transmission
Not Considered OPIM
•Vomit
•Perspiration
•Tears
•Urine
•Feces
9
Human Immunodeficiency Virus
•Target in Body
immune system
•Risk (contaminated needlestick) 0.3% (1 in 300 chance)
•Risk (splash to mucous membrane) 0.1% (1 in 1000 chance)
3 to 5 hrs
•External viability
no
•Vaccine Available
HIV
Time Span (?)
AIDS
Source: Centers for Disease Control and Prevention
http://www.cdc.gov/OralHealth/infectioncontrol/faq/bloodborne_exposures.htm
10
HIV Basics Statistics
•About 50,000 people get infected in the US with
HIV each year.
•About 1.2 million people in the US were living with
HIV at the end of 2011, the most recent year this
information was available.
•Worldwide, there were about 2.1 million new cases of
HIV in 2013. About 35 million people are living with
HIV around the world.
Source: Centers for Disease Control and Prevention
http://www.cdc.gov/hiv/statistics/basics.html
11
Bloodborne diseases and their transmission
Hepatitis
•“Hepa” = liver; “titis” = inflammation of
•6 types = A, B, C, D, E, and G
•Types B (HBV) and C are bloodborne
•Type D and G only occurs in those already
infected with type B
•Types A, E spread through fecal-oral mode of
transmission
•Hepatitis B and C can be ACUTE or CHRONIC
12
Bloodborne diseases and their transmission
Hepatitis B virus
•Target in Body
•Risk from contaminated needlestick
•External viability
•Vaccine Available
liver
6% - 30%*
7 days
yes
*depends on the hepatitis Be antigen (HBeAg) status of the source individual
Source: Centers for Disease Control and Prevention
http://www.cdc.gov/OralHealth/infectioncontrol/faq/bloodborne_exposures.htm
13
Bloodborne diseases and their transmission
HBV Confirmed Transmission
Percutaneous (i.e., puncture through skin) or mucosal contact
with infectious blood or body fluids (e.g., seman, saliva),
including:
•Sex with an infected partner
•Contaminated needles (esp. I.V. drug use)
•Birth to an infected mother
•Contact with blood or open sores of an infected person
•Sharing items such as razors or toothbrushes with
an infected person
Source: Centers for Disease Control and Prevention
http://www.cdc.gov/hepatitis/HBV/HBVfaq.htm#b1
14
Bloodborne diseases and their transmission
HBV Symptoms
30% to 50% of people have initial signs and symptoms.
When present, they can include:
•Nausea, vomiting, fever, abdominal or joint pain
•Loss of appetite
•Fatigue
•Yellowing of the skin or eyes
•Dark Urine
•Clay-colored bowel movements
Source: Centers for Disease Control and Prevention
http://www.cdc.gov/hepatitis/HBV/HBVfaq.htm#b6
15
Bloodborne diseases and their transmission
HBV facts (U.S.)
•About 95% of adults who are exposed to HBV fully recover
within 6 months (acute HBV) without medication.
•About 5% have HBV all their lives (chronic HBV) unless
they are successfully treated with medications.
•The rate of new HBV infections has declined by 82% since
1991 when vaccination of children was first recommended.
Source: Centers for Disease Control and Prevention
http://www.cdc.gov/hepatitis/hbv/hbvfaq.htm#overview
16
Exposure Control
Methods
1. Signs and Labels
2. Exposure Control Plan
3. Engineering Controls
4. Personal Protective Equipment
5. First Aid Situations
6. Contaminated waste disposal
7. Contaminated laundry
17
Exposure Control Methods
1. Signs and Labels
•“Medical Waste”
•“Infectious Waste”
•“Infectious”
•“Biohazard”
18
Exposure Control Methods
2. Exposure Control Plan
Covers:
•Spill response
•Housekeeping
•HBV program
•Exposure incidents
•Infectious waste disposal
•PPE
•Work practices
Availability - BBP Trainer or ESRM at:
http://http://www.units.miamioh.edu/esrm/training/bloodborne-pathogen-training
pathogen-training
19
Exposure Control Methods
3. Engineering Controls
Examples: •Sharps Containers
•Biohazard waste bags & boxes
•One-way valves on resuscitation devices
•Hand washing facilities
20
Exposure Control Methods
4. Personal Protective Equipment
•Types
•Limitations
21
Exposure Control Methods
5. First Aid Situations
•University Police are designated first responders
•Encourage self-care if possible
•Avoid bare-hand pressure without barrier
•Glove accessibility
22
Exposure Control Methods
6. Contaminated Waste Disposal
•Infectious Waste
•Red bags
•Labeling requirements
•Biohazard boxes
•Drop-off sites
•Sharps disposal
23
Exposure Control Methods
7. Contaminated Laundry
•Wear gloves for handling and
thoroughly wash hands afterwards
•If blood or OPIM gets on personal
clothing, remove it and wash the clothing
as soon as feasible following the detergent
manufacturer’s directions.
24
Exposure Incidents
Blood or OPIM Contacts:
1. Mucous membranes
Eyes
Mouth
Nose
2. Non-intact skin
3. Contaminated Sharp
25
Exposure Incidents
Exposure Incident Examples
•Blood/OPIM splash on non-healthy or non-intact skin
(e.g., rash, a recent cut, chapped skin, broken cuticles,
skin that is chafed, scraped, etc.)
•Blood/OPIM splash to eyes, nose, or mouth
•Puncture injuries with potentially contaminated object
(e.g., needlesticks, contaminated glass, etc.)
•Rubbing eyes or nose with contaminated gloves or
clothing
26
Exposure Incidents
Post-exposure evaluation
and follow-up
•Confidential medical evaluation and blood
testing offered at no cost to employee
•Voluntary
28
Exposure Incidents
What is involved in
an exposure evaluation?
•Report to Miami’s Convenient Care Clinic or the
Nursing Supervisor at Student Health Services
•Medical personnel will document how the
exposure occurred and the route of entry
•They will request the identity of the source
individual and seek consent to test their blood
for hepatitis and HIV (you will be given the
results of these tests)
29
Exposure Incidents
Post-exposure testing
•Voluntary blood tests
•HIV antibody test requires
several blood tests over a period
of time
•If medically indicated, you will
be offered a vaccine for
Hepatitis B
•Recordkeeping
30
HBV vaccine
•Noninfectious
•Produced in yeast cells
•Developed free of human blood or blood products
•Used to promote immunity to HB infection in
individuals considered at high risk of potentially
being exposed to the virus
31
HBV vaccine
HBV program at Miami University
•Eligibility requirements*
•Administration site (Student Health Services)
•Schedule (Call SHS for appointment)
•Consent / Declination procedures
* Employees determined to have a reasonably anticipated
high risk of occupational exposure
32
HBV vaccine
Pre- vs. Post-exposure vaccination
•Preventive / pre-exposure vaccination protects against
unidentified exposure incidents
•Vaccine series may be initiated following exposure incident
–Best started within 48 - 72 hours
–Student Health Services suggests initiation no later than
7 days after exposure
–70 to 75% effective in preventing HBV infection
33
HBV vaccine
Side Effects
•Local effects: redness, soreness, swelling, firmness at site
of injection
•Generalized effects: slight fever, nausea, vomiting,
diarrhea, headache, chills, mild muscle aches and/or joint
pain
•Allergic / hypersensitivity reaction: rash, itching, swelling
not limited to injection site
•No known harmful effects if previously infected or
positive for HBV antibody
34
HBV vaccine
Contraindications
(Conditions suggesting treatment
should not be administered)
•Yeast allergy
•Serious allergic reaction to a prior dose
of Hepatitis B vaccine
•Serious allergic reaction to a component
of the Hepatitis B Vaccine
Source: Centers for Disease Control and Prevention
http://http://www.cdc.gov/hepatitis/hbv/hbvfaq.htm#overview
35
HBV vaccine
Efficacy
(Vaccine’s effectiveness)
•Active immunity in greater than 95% of persons
completing the series of three injections
•Immunity projected to last indefinitely
•Positive immunity protects against all modes of
transmission
•May donate blood if vaccine given as a preventive
measure
36
Spill cleanup
•Kits
•Decontamination
•Precautions
•Procedure
37
Spill cleanup
Spill cleanup kits
•Accessibility requirements
•Know the locations of the kits in your work area
and make sure you have easy access to them
•Know how to use your department’s kit
•Follow directions included with the kit and use all
personal protective equipment provided in it
38
Spill cleanup
Decontamination
•Use 10% bleach solution for 15-minute soak time*
•Undiluted bleach for a minimum exposure of 30 seconds
•EPA-registered TUBERCULOCIDAL disinfectants
•Check the label of the disinfectant you are using.
“HIV-Effective” does NOT necessarily mean it is effective
against hepatitis viruses.
*mix solution and use within 24 hours
39
Spill cleanup
Spill cleanup precautions
•Minimize spread of spill
•Avoid splashing or spraying
•Assume gloved hands are contaminated
•Avoid using brushes or brooms
•Dispose of sharps appropriately
40
Spill cleanup
Spill cleanup procedure
1. Secure the site (keep others away)
2. Inspect and put on appropriate PPE
3. In an area free of contamination, position red
bag so materials can be dropped in without
soiling outside of bag
4. Carefully use only as much decontaminant as
you need to saturate the spill area, cover with
paper towels, and allow to soak
41
Spill cleanup
Spill cleanup procedure
5. For non-level surfaces (e.g., walls), thoroughly
clean area with 10% bleach solution (or other
EPA-approved disinfectant) and allow to air dry
6. Dispose of sharp objects in a sharps container or a
sturdy puncture-resistant container
7. Place all materials in red bag
8. Remove disposable PPE and place in red bag
42
Spill cleanup
Spill cleanup procedure
9. Touching outside of red bag only, close and secure
with twist tie or knot
10. Decontaminate area again and allow to air dry
11. Arrange for pickup and disposal of red bag
12. Wash your hands with soap and water!
43
BLOODBORNE PATHOGENS
Course Revision
2015
Miami University
Environmental Health and Safety Offices
44
Information
You are encouraged to contact your BBP Trainer or
the Environmental Safety & Risk Management Offices
to discuss questions you may have regarding this program.
Refer to the following websites for more information:
http://www.units.miamioh.edu/esrm/training/bloodborne-pathogen-training
http://www.liverfoundation.org
http://www.cdc.gov
45